User profiles for Mateusz M Plucinski

Mateusz Plucinski

CDC
Verified email at cdc.gov
Cited by 3030

[HTML][HTML] Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P. 1 variant

…, TP Portella, S Poloni, C Franco, MM Plucinski… - Communications …, 2021 - nature.com
Background The SARS-CoV-2 variant of concern (VOC) P.1 (Gamma variant) emerged in
the Amazonas State, Brazil, in November 2020. The epidemiological consequences of its …

[HTML][HTML] Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities

MM Plucinski, T Guilavogui, S Sidikiba… - The Lancet infectious …, 2015 - thelancet.com
Background The ongoing west Africa Ebola-virus-disease epidemic has disrupted the entire
health-care system in affected countries. Because of the overlap of symptoms of Ebola virus …

[HTML][HTML] Persisting viral sequences shape microbial CRISPR-based immunity

AD Weinberger, CL Sun, MM Pluciński… - PLoS computational …, 2012 - journals.plos.org
Well-studied innate immune systems exist throughout bacteria and archaea, but a more
recently discovered genomic locus may offer prokaryotes surprising immunological adaptability. …

[HTML][HTML] Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign

…, SA Okoth, K Congpuong, MM Plucinski… - PLoS …, 2015 - journals.plos.org
The recent emergence of artemisinin resistance in the Greater Mekong Subregion poses a
major threat to the global effort to control malaria. Tracking the spread and evolution of …

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uige Provinces, angola

MM Plucinski, E Talundzic, L Morton… - Antimicrobial agents …, 2015 - Am Soc Microbiol
The development of resistance to antimalarials is a major challenge for global malaria
control. Artemisinin-based combination therapies, the newest class of antimalarials, are used …

[HTML][HTML] Poverty, disease, and the ecology of complex systems

CN Ngonghala, MM Pluciński, MB Murray… - PLoS …, 2014 - journals.plos.org
Understanding why some human populations remain persistently poor remains a significant
challenge for both the social and natural sciences. The extremely poor are generally reliant …

[HTML][HTML] Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum …

MM Plucinski, PR Dimbu, AP Macaia, CM Ferreira… - Malaria Journal, 2017 - Springer
Background Recent anti-malarial resistance monitoring in Angola has shown efficacy of
artemether–lumefantrine (AL) in certain sites approaching the key 90% lower limit of efficacy …

Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship

MM Plucinski, M Wallace, A Uehara… - Clinical Infectious …, 2021 - academic.oup.com
Background The Diamond Princess cruise ship was the site of a large outbreak of coronavirus
disease 2019 (COVID-19). Of 437 Americans and their travel companions on the ship, …

Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay

MM Plucinski, C Herman, S Jones… - The Journal of …, 2019 - academic.oup.com
Background Detection of Plasmodium antigens provides evidence of malaria infection
status and is the basis for most malaria diagnosis. Methods We developed a sensitive bead-…

[HTML][HTML] Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated …

…, ES Halsey, JF Martins, F Fortes, MM Plucinski - Malaria journal, 2018 - Springer
Background The Angolan government recommends three artemisinin-based combinations
for the treatment of uncomplicated Plasmodium falciparum malaria: artemether–lumefantrine (…